首页 > 抗体蛋白 > 抗体
APC anti-mouse CD62L Antibody
产品名称:
APC anti-mouse CD62L Antibody
产品类别:
抗体
产品编号:
104411
产品应用:
104411
[价格]
规格 价格 库存
25µg ¥ 792 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/eb mouse B lymphoma 38C-13
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1-3, complement-dependent cytotoxicity4, in vivo and in vitro blocking of adhesion1-3,5, and immunohistochemical staining of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections6. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. Nos. 104457-104462).

Application References

(PubMed link indicates BioLegend citation)
  1. Gallatin WM, et al. 1983. Nature 304:30. (IP, Block)
  2. Siegelman MH, et al. 1990. Cell 61:611. (IP, Block)
  3. Lewinsohn DM, et al. 1987. J. Immunol. 138:4313. (IP, Block)
  4. Iwabuchi K, et al. 1991. Immunobiology 182:161. (CMCD)
  5. Pizcueta P, et al. 1994. Am. J. Pathol. 145:461.
  6. Reichert RA, et al. 1986. J. Immunol. 136:3535. (IHC, FC)
  7. Olver S, et al. 2006. Cancer Res. 66:571.
  8. Fukushima A, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:657. PubMed
  9. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  10. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed
  11. Lee JW, et al. 2006. Nature Immunol. 8:181.
  12. Shigeta A, et al. 2008. Blood 112:4915 (FC) PubMed
  13. de Vries VC, et al. 2009. Am. J. Transplant. 9:2270 PubMed
Product Citations
  1. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  2. Cowan J, et al. 2013. J Exp Med. 210:675. PubMed
  3. Ender F, et al. 2017. PLoS One. 12(2):e0172446. PubMed
  4. Sun L, et al. 2021. Cancer Cell. :. PubMed
  5. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  6. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  7. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  8. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  9. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  10. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  11. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  12. Wang J, et al. 2012. Blood. 120:1489. PubMed
  13. Martens R, et al. 2020. Nat Commun. 11:1114. PubMed
  14. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  15. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  16. Wei H, et al. 2021. Malar J. 20:89. PubMed
  17. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  18. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  19. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  20. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  21. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  22. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  23. Gilleron J et al. 2018. Cell reports. 25(12):3329-3341 . PubMed
  24. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  25. Zhao Y, et al. 2021. J Biol Chem. 297:101166. PubMed
  26. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  27. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  28. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  29. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  30. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  31. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  32. Roy S, et al. 2020. Sci Rep. 10:10992. PubMed
  33. Li Y, et al. 2020. Nat Commun. 11:2781. PubMed
  34. Parriott G, et al. 2020. Immunology. 160:280. PubMed
  35. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  36. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  37. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  38. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  39. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  40. Ma X et al. 2019. Cell Metab. 30(1):143-156 . PubMed
  41. Deng B, et al. 2022. J Immunother Cancer. 10:. PubMed
  42. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  43. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  44. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  45. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  46. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  47. Darragh LB, et al. 2022. Nat Commun. 13:7015. PubMed
  48. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  49. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
  50. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  51. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  52. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  53. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  54. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  55. Glassman CR, et al. 2021. eLife. 10:00. PubMed
  56. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  57. Su X, et al. 2022. J Transl Med. 20:378. PubMed
  58. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  59. Cowan J, et al. 2014. J Immunol. 193:1204. PubMed
  60. White C, et al. 2015. J Immunol. 194:697. PubMed
  61. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  62. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  63. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  64. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  65. Morimoto Y, et al. 2018. Immunity. 49:134. PubMed
  66. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  67. Ma K, et al. 2022. iScience. 25:104347. PubMed
  68. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  69. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  70. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  71. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  72. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  73. Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
  74. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  75. Jenkinson W, et al. 2012. PLoS One. 7:e53416. PubMed
  76. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  77. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  78. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  79. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  80. Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
  81. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  82. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  83. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  84. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  85. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  86. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  87. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  88. Webb LM, et al. 2020. J Clin Invest. 130:1683. PubMed
  89. Shimba A et al. 2018. Immunity. 48(2):286-298 . PubMed
  90. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  91. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  92. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  93. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  94. Kooijman S, et al. 2015. Am J Physiol Heart Circ Physiol. 309: H646-H654. PubMed
  95. Lin JD, et al. 2020. Cell Host & Microbe. 27(5):830-840. PubMed
  96. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  97. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  98. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  99. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  100. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  101. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  102. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  103. Yu Z, et al. 2021. Biomed Res Int. 2021:9958745. PubMed
  104. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  105. Louise V Webb et al. 2019. Immunity. 50(2):348-361 . PubMed
  106. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
RRID
AB_313098 (BioLegend Cat. No. 104411) AB_313099 (BioLegend Cat. No. 104412)

Antigen Details

Structure
Selectin, 95 kD (neutrophils) or 74 kD (lymphocytes)
Distribution

Subsets of B and T cells, monocytes, granulocytes, subset of NK cells

Function
Lymphocyte homing to HEV, rolling on activated endothelium
Ligand/Receptor
CD34, GlyCAM-1, MAdCAM-1
Cell Type
B cells, Granulocytes, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Kishimoto TK, et al. 1990. P. Natl. Acad. Sci. USA 87:2244.
3. Tedder TF, et al. 1995. J. Exp. Med. 181:2259.

Gene ID
20343 View all products for this Gene ID
UniProt
View information about CD62L on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线